Compare NextEra Energy, Inc. (NEE) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NextEra Energy, Inc. vs Regeneron Pharmaceuticals Inc — how do they compare? NextEra Energy, Inc. trades at $87.93 (market cap $183.53B), while Regeneron Pharmaceuticals Inc trades at $680.5 (market cap $70.47B). The key difference: NextEra Energy, Inc. is far larger — about 2.6× Regeneron Pharmaceuticals Inc's market cap, and NextEra Energy, Inc. pays the higher dividend (2.83%). Which is the better fit depends on your goals.
| NEE | REGN | |
|---|---|---|
Market Cap | $183.53B | $70.47B |
Sector | Utilities | Health |
52-Week High | $97.88 | $812.27 |
52-Week Low | $69.77 | $545.46 |
Enterprise Value | $285.94B | $64.42B |
Dividend Yield | 2.83% | 0.56% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About NextEra Energy, Inc.
NextEra Energy's regulated utility, Florida Power & Light, distributes power to more than 5 million customers in Florida. FP&L contributes more than 60% of the group's operating earnings. The renewable energy segment generates and sells power throughout the United States and Canada. Consolidated generation capacity totals more than 50 gigawatts and includes natural gas, nuclear, wind, and solar assets.
Read more on NEE →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
